318 related articles for article (PubMed ID: 9294476)
1. Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients.
Lote K; Egeland T; Hager B; Stenwig B; Skullerud K; Berg-Johnsen J; Storm-Mathisen I; Hirschberg H
J Clin Oncol; 1997 Sep; 15(9):3129-40. PubMed ID: 9294476
[TBL] [Abstract][Full Text] [Related]
2. Clinical features, management and outcomes of high-grade glioma patients in Ramathibodi Hospital.
Chansriwong P; Sirisinha T
J Med Assoc Thai; 2010 Feb; 93 Suppl 2():S68-73. PubMed ID: 21299082
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors and survival in a prospective cohort of patients with high-grade glioma treated with carmustine wafers or temozolomide on an intention-to-treat basis.
Catalán-Uribarrena G; Bilbao-Barandica G; Pomposo-Gaztelu I; Undabeitia-Huertas J; Ruiz de Gopegui-Ruiz E; Galbarriatu-Gutiérrez L; Canales-Llantada M; Aurrecoechea-Obieta J; Igartua-Azkune A; Carbayo-Lozano G
Acta Neurochir (Wien); 2012 Feb; 154(2):211-22; discussion 222. PubMed ID: 22002506
[TBL] [Abstract][Full Text] [Related]
4. Favorable prognosis in patients with high-grade glioma with radiation necrosis: the University of Colorado reoperation series.
Rusthoven KE; Olsen C; Franklin W; Kleinschmidt-DeMasters BK; Kavanagh BD; Gaspar LE; Lillehei K; Waziri A; Damek DM; Chen C
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):211-7. PubMed ID: 20732762
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of prognostic factors on survival in patients with low grade glioma.
Durmaz R; Vural M; Işildi E; Coşan E; Ozkara E; Bal C; Ciftçi E; Arslantaş A; Atasoy MA
Turk Neurosurg; 2008 Oct; 18(4):336-44. PubMed ID: 19107679
[TBL] [Abstract][Full Text] [Related]
6. [Survival of newly diagnosed malignant glioma patients on combined modality therapy].
Yang QY; Shen D; Sai K; Jiang XB; Ke C; Zhang XH; Mou YG; Chen ZP
Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(1):8-10. PubMed ID: 23578444
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.
Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M
J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394
[TBL] [Abstract][Full Text] [Related]
8. Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: a report of Radiation Therapy Oncology Group (RTOG) 83-02.
Murray KJ; Nelson DF; Scott C; Fischbach AJ; Porter A; Farnan N; Curran WJ
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):453-9. PubMed ID: 7852106
[TBL] [Abstract][Full Text] [Related]
9. Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma.
Taylor BV; Buckner JC; Cascino TL; O'Fallon JR; Schaefer PL; Dinapoli RP; Schomberg P
J Clin Oncol; 1998 Jun; 16(6):2195-201. PubMed ID: 9626221
[TBL] [Abstract][Full Text] [Related]
10. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
Gnekow AK; Kortmann RD; Pietsch T; Emser A
Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
[TBL] [Abstract][Full Text] [Related]
11. Low-grade gliomas.
Stieber VW
Curr Treat Options Oncol; 2001 Dec; 2(6):495-506. PubMed ID: 12057095
[TBL] [Abstract][Full Text] [Related]
12. The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine.
Selker RG; Shapiro WR; Burger P; Blackwood MS; Arena VC; Gilder JC; Malkin MG; Mealey JJ; Neal JH; Olson J; Robertson JT; Barnett GH; Bloomfield S; Albright R; Hochberg FH; Hiesiger E; Green S;
Neurosurgery; 2002 Aug; 51(2):343-55; discussion 355-7. PubMed ID: 12182772
[TBL] [Abstract][Full Text] [Related]
13. Evaluating glioma therapies: modeling treatments and predicting outcomes.
Kirby S; Brothers M; Irish W; Florell R; Macdonald D; Schold C; Cairncross G
J Natl Cancer Inst; 1995 Dec; 87(24):1884-8. PubMed ID: 7494233
[TBL] [Abstract][Full Text] [Related]
14. Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: A population-based study.
Krishnatry R; Zhukova N; Guerreiro Stucklin AS; Pole JD; Mistry M; Fried I; Ramaswamy V; Bartels U; Huang A; Laperriere N; Dirks P; Nathan PC; Greenberg M; Malkin D; Hawkins C; Bandopadhayay P; Kieran MW; Manley PE; Bouffet E; Tabori U
Cancer; 2016 Apr; 122(8):1261-9. PubMed ID: 26970559
[TBL] [Abstract][Full Text] [Related]
15. Retrospective comparison of chemoradiotherapy followed by adjuvant chemotherapy, with or without prior gliadel implantation (carmustine) after initial surgery in patients with newly diagnosed high-grade gliomas.
Noël G; Schott R; Froelich S; Gaub MP; Boyer P; Fischer-Lokou D; Dufour P; Kehrli P; Maitrot D
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):749-55. PubMed ID: 21300471
[TBL] [Abstract][Full Text] [Related]
16. Risk Factors for Malignant Transformation of Low-Grade Glioma.
Murphy ES; Leyrer CM; Parsons M; Suh JH; Chao ST; Yu JS; Kotecha R; Jia X; Peereboom DM; Prayson RA; Stevens GHJ; Barnett GH; Vogelbaum MA; Ahluwalia MS
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):965-971. PubMed ID: 29485076
[TBL] [Abstract][Full Text] [Related]
17. Survival outcome and neurotoxicity in patients of high-grade gliomas treated with conformal radiation and temozolamide.
Anand AK; Chaudhory AR; Aggarwal HN; Sachdeva PK; Negi PS; Sinha SN; Babu AG; Jena A; Rao A; Chaudhury PS
J Cancer Res Ther; 2012; 8(1):50-6. PubMed ID: 22531514
[TBL] [Abstract][Full Text] [Related]
18. Supratentorial low-grade glioma: results and prognostic factors following postoperative radiotherapy.
Grabenbauer GG; Roedel CM; Paulus W; Ganslandt O; Schuchardt U; Buchfelder M; Schrell U; Fahlbusch R; Huk WJ; Sauer R
Strahlenther Onkol; 2000 Jun; 176(6):259-64. PubMed ID: 10897252
[TBL] [Abstract][Full Text] [Related]
19. A phase III study of radiation therapy plus carmustine with or without recombinant interferon-alpha in the treatment of patients with newly diagnosed high-grade glioma.
Buckner JC; Schomberg PJ; McGinnis WL; Cascino TL; Scheithauer BW; O'Fallon JR; Morton RF; Kuross SA; Mailliard JA; Hatfield AK; Cole JT; Steen PD; Bernath AM
Cancer; 2001 Jul; 92(2):420-33. PubMed ID: 11466698
[TBL] [Abstract][Full Text] [Related]
20. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study.
Shaw E; Arusell R; Scheithauer B; O'Fallon J; O'Neill B; Dinapoli R; Nelson D; Earle J; Jones C; Cascino T; Nichols D; Ivnik R; Hellman R; Curran W; Abrams R
J Clin Oncol; 2002 May; 20(9):2267-76. PubMed ID: 11980997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
